<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35133956</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerg Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Long-Term Symptoms among COVID-19 Survivors in Prospective Cohort Study, Brazil.</ArticleTitle><Pagination><StartPage>730</StartPage><EndPage>733</EndPage><MedlinePgn>730-733</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2803.212020</ELocationID><Abstract><AbstractText>We conducted a prospective cohort study in a population with diverse ethnic backgrounds from Brazil to assess clinically meaningful symptoms after surviving coronavirus disease. For most of the 175 patients in the study, clinically meaningful symptoms, including fatigue, dyspnea, cough, headache, and muscle weakness, persisted for &gt;120 days after disease onset.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonif&#xe1;cio</LastName><ForeName>L&#xed;via P</ForeName><Initials>LP</Initials></Author><Author ValidYN="Y"><LastName>Csizmar</LastName><ForeName>Viviane N F</ForeName><Initials>VNF</Initials></Author><Author ValidYN="Y"><LastName>Barbosa-J&#xfa;nior</LastName><ForeName>Francisco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Ana P S</ForeName><Initials>APS</Initials></Author><Author ValidYN="Y"><LastName>Koenigkam-Santos</LastName><ForeName>Marcel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wada</LastName><ForeName>Danilo T</ForeName><Initials>DT</Initials></Author><Author ValidYN="Y"><LastName>Gaspar</LastName><ForeName>Gilberto G</ForeName><Initials>GG</Initials></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Felipe S</ForeName><Initials>FS</Initials></Author><Author ValidYN="Y"><LastName>Bollela</LastName><ForeName>Valdes R</ForeName><Initials>VR</Initials></Author><Author ValidYN="Y"><LastName>Santana</LastName><ForeName>Rodrigo C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Jo&#xe3;o P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Bellissimo-Rodrigues</LastName><ForeName>Fernando</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brazil</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cohort</Keyword><Keyword MajorTopicYN="N">coronavirus disease</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID condition</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword><Keyword MajorTopicYN="N">viruses</Keyword><Keyword MajorTopicYN="N">zoonoses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>8</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35133956</ArticleId><ArticleId IdType="pmc">PMC8888217</ArticleId><ArticleId IdType="doi">10.3201/eid2803.212020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Emergency use ICD codes for COVID-19 disease outbreak [cited 2021 May 3]. https://www.who.int/standards/classifications/classification-of-diseases/emergency-use-icd-codes-for-covid-19-disease-outbreak</Citation></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325:2015&#x2013;6. 10.1001/jama.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Instituto Brasileiro de Geografia e Estat&#xed;stica. Geographic and statistical overview of Ribeir&#xe3;o Preto [in Portuguese] [cited 2021 Mar 29]. https://cidades.ibge.gov.br/brasil/sp/ribeirao-preto/panorama</Citation></Reference><Reference><Citation>World Health Organization. Global COVID-19 clinical platform case report form (CRF) for post COVID condition (Post COVID-19 CRF) [cited 2020 Oct 20]. https://cdn.who.int/media/docs/default-source/3rd-edl-submissions/who_crf_postcovid_feb9_2021.pdf</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551&#x2013;8. 10.1017/S0033291798006667</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291798006667</ArticleId><ArticleId IdType="pubmed">9626712</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref] [in Portuguese]. Rev Saude Publica. 2000;34:178&#x2013;83. 10.1590/S0034-89102000000200012</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0034-89102000000200012</ArticleId><ArticleId IdType="pubmed">10881154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroso B, Pilatti LA, Gutierrez GL, Picinin CT. Calculating WHOQOL-BREF scores and descriptive statistics through Microsoft Excel [in Portuguese]. Revista Brasileira de Qualidade de Vida. 2010;2:31&#x2013;6. 10.3895/S2175-08582010000100004</Citation><ArticleIdList><ArticleId IdType="doi">10.3895/S2175-08582010000100004</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. COVID-19: Long-term effects [cited 2021 May 3]. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Nature. Long COVID. Long COVID: let patients help define long-lasting COVID symptoms. [editorial]. Nature. 2020;586:170. 10.1038/d41586-020-02796-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I; CoviCare Study Team. CoviCare Study Team. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021;174:1252&#x2013;60. 10.7326/M21-0878</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis. 2021;ciab611; [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Antwi-Amoabeng D, Beutler BD, Singh S, Taha M, Ghuman J, Hanfy A, et al. Association between electrocardiographic features and mortality in COVID-19 patients. Ann Noninvasive Electrocardiol. 2021;26:e12833. 10.1111/anec.12833</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12833</ArticleId><ArticleId IdType="pmc">PMC8250310</ArticleId><ArticleId IdType="pubmed">33742501</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am Heart J Plus. 2021;5:100025. 10.1016/j.ahjo.2021.100025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>